Vaccine manufacturer Bharat Biotech International Limited (BBIL) is making a foray into the cell and gene therapy (CGT) space ...
Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, ...
The International Symposium on “Harnessing Genome Editing for Resilient Agriculture” concluded at the Gurdev Singh Khush ...
TB One’ Solution is a pre-sequencing kit that enables the preparation of a ready-to-sequence library from TB DNA.
Dr. Raches Ella, Chief Development Officer, Bharat Biotech, spearheading this CGT initiative, said that oncology and rare ...
Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...
With initiatives like the Production Linked Incentive (PLI) schemes for pharma, bulk drugs and medical devices, along with the Genome India project, Goyal said India is poised to lead the next ...
India’s bioeconomy has witnessed a remarkable 16 fold growth in 10 years of the past one decade, from less than $ 10 Billion ...
BBIL's 50,000-square-foot CGT facility advances its mission to deliver life-saving treatments for haematological malignancies ...